Corporate Turnaround of Pharmacia & Upjohn
|
|
ICMR HOME | Case Studies Collection
Case Details:
Case Code : BSTR255
Case Length : 17 Pages
Period : 1995-2006
Pub Date : 2007
Teaching Note :Not Available
Organization : Pharmacia & Upjohn
Industry : Pharma
Countries : US / Sweden
To download Corporate Turnaround of Pharmacia & Upjohn case study (Case Code:
BSTR255) click on the button below, and select the case from the list of available cases:
Price:
For delivery in electronic format: Rs. 400;
For delivery through courier (within India): Rs. 400 + Rs. 25 for Shipping & Handling Charges
» Business Strategy Case Studies
» Case Studies Collection
» Business Strategy Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
|
|
<< Previous
Pfizer Acquires Pharmacia Contd...
|
However, despite the synergies between Pharmacia and Upjohn, the merger did not
yield the expected results. This was mainly due to the cultural differences
between the companies.
The merged entity reported poor earnings and this was attributed to the
confusion created in the company by the merger. To begin with, Pharmacia and
Upjohn could not reach an agreement on where the corporate headquarters should
be located.
Besides, there were differences between the top executives of both companies,
which led to a lack of cooperation between them.
|
|
The company's efforts were not directed at achieving the
synergies and financial goals of the merger, and this resulted in the exodus of
several talented employees. This had an adverse affect on sales and the company
issued profit warnings for four quarters in a row in 1997. The merger costs
exceeded the budget by more than US$ 500 million.
Between 1996 and 1997, Pharmacia and Upjohn's combined sales dropped by 8% to
US$ 6.6 billion. The earnings went down by 53% from US$ 550 million to US$ 258
million.
|
|
It was in such a scenario that Fred Hassan (Hassan),
Executive Vice-President, American Home Products5
(later Wyeth), joined Pharmacia & Upjohn as CEO in May 1997. Hassan was
largely responsible for turning the company around. By the third quarter
of 1998, the company was back on track and had begun showing a growth in
profits. The net income reached US$ 799 million by 1999, growing by 14%
over the previous year.
With the 1999 merger with Monsanto, the Pharmacia Corporation was
formed. The growth continued and by mid-2002, the company was acquired
by Pfizer (Refer to Exhibit I and Exhibit II for the financial details
of Pharmacia & Upjohn and Pharmacia Corporation)... |
Excerpts >>
|
